Pages
Products
AAV5-hSyn-Cre

AAV5-hSyn-Cre

Cat.No. :  AAV00504Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 5 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00504Z
Description AAV serotype 5 particles express Cre recombinase under the control of human Synapsin promoter for neuronal specific expression.
Serotype AAV Serotype 5
Target Gene Cre
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

To date, approximately 80% of the more than 7,000 diseases known to date are caused by defective genes. Gene therapy holds the promise of repairing errors in a patient's genetic coding with a one-time treatment regimen. Recombinant viruses are highly efficient vectors for in vivo gene delivery. Adeno-associated virus (AAV) vectors have unique advantages, such as tissue tropism, transduction specificity, relatively low immune response, no integration into host chromosomes, and persistent gene expression, making them the most popular viral gene delivery system in clinical trials. Three AAV-based gene therapy drugs have been approved by the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Tissue tropism reflects the specific interaction between serotype-specific structures on the rAAV capsid and cellular glycans and receptors. Initial binding of many AAV serotypes is through primary receptors, including glycans and proteoglycans such as heparan sulfate, terminal galactose (Gal), and several linked variants of sialic acid (SA). AAV serotype vectors can be divided into three categories based on their glycan receptor usage: heparan sulfate proteoglycan (HSPG) for AAV2, AAV3, AAV6, and AAV13; sialic acid (SA) for AAV1, AAV4, AAV5, and AAV6; and Gal for AAV9.

Clock neurons within the mammalian suprachiasmatic nucleus (SCN) encode circadian time using an interlocking transcription-translation feedback loop (TTFL) to drive rhythmic gene expression. However, the contribution of transcription factors beyond the circadian TTFL to SCN function remains unclear. Here, researchers report that the stem and progenitor transcription factor, sex-determining region Y-box 2 (SOX2), is expressed in adult SCN neurons and positively regulates transcription of the core clock gene Period2. Mice lacking SOX2 selectively in SCN neurons exhibit imprecise, poorly consolidated behavioral rhythms that fail to effectively synchronize to the ambient light cycle and are highly susceptible to sustained light-induced arrhythmias. RNA sequencing reveals that Sox2 deficiency alters the SCN transcriptome, reducing expression of core clock genes and neuropeptide receptor systems. By defining the transcriptional landscape within SCN neurons, SOX2 enables the generation of stable, trainable circadian rhythms that accurately reflect environmental time.

To determine whether the effects of Sox2 disruption on PER2 expression were intrinsic to the fully developed SCN, researchers used adeno-associated virus (AAV)-mediated delivery of cre recombinase to ablate the Sox2 gene in neurons in SCN tissue explants prepared from Sox2fl/fl;Per2Luc/+ pups at postnatal day (P) 12 (Figure 1K) and monitored PER2::LUCIFERASE rhythms in culture. As most developmental milestones of the mouse SCN have been reached by ∼P10, this approach could avoid any potential effects of Sox2 ablation on SCN development. The amplitude of PER2::LUC rhythms was significantly reduced in cultures transduced with AAV5-hSyn-Cre compared with SCN explants transduced with control AAV5-human synaptobrevin (hSyn)-TurboRFP (Figures 1L and 1M). Collectively, these data suggest that SOX2 is important for the generation of high-amplitude PER2 rhythms within the SCN.

Figure 1. (K) SOX2 (green) and RFP (magenta) expression in Sox2fl/fl;Per2Luc/+ SCN tissue explants transduced with AAV5-hSyn-TurboRFP or AAV5-hSyn-Cre. (L) Bioluminescence traces from Sox2fl/fl;Per2Luc/+ SCN tissue explants that had been transduced with AAV5-hSyn-TurboRFP or AAV5-hSyn-Cre on day 5 after initial plating. (M) Relative amplitude of bioluminescence rhythms of transduced Sox2fl/fl;Per2Luc/+ SCN tissue explants after medium change.Figure 1. (K) SOX2 (green) and RFP (magenta) expression in Sox2fl/fl;Per2Luc/+ SCN tissue explants transduced with AAV5-hSyn-TurboRFP or AAV5-hSyn-Cre. (L) Bioluminescence traces from Sox2fl/fl;Per2Luc/+ SCN tissue explants that had been transduced with AAV5-hSyn-TurboRFP or AAV5-hSyn-Cre on day 5 after initial plating. (M) Relative amplitude of bioluminescence rhythms of transduced Sox2fl/fl;Per2Luc/+ SCN tissue explants after medium change. (Cheng A H, et al., 2019)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Reliable Performance

We achieved remarkable transduction rates in both primary cell cultures and animal models, demonstrating this vector's versatility and efficacy.

United Kingdom

12/30/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER